We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
PolyMedica announced that it has entered into a $150 million, five-year revolving
credit facility with a syndicate of banks led by Bank of America and Wachovia.
Rockwell Medical Technologies, a dialysis products manufacturer serving the
healthcare industry, reported that it has secured $6.5 million in business with
a new customer.
SpectruMedix announced the launch of a new application package to the Reveal
Genetic Analysis System: human bacterial and viral pathogen (HBVP) detection
and identification.
SourceOne Healthcare Technologies and Shimadzu Medical Systems, a division of
Shimadzu Precision Instruments, announced the companies have signed a contract
giving SourceOne nationwide rights to market and distribute an innovative and
affordable mobile X-ray system specifically manufactured by Shimadzu for SourceOne.
Competitive Technologies (CTT) announced that a homocysteine assay license has
been granted to the Diagnostics Division of Roche under CTT's U.S. Patent Number
4,940,658 relating to homocysteine medical tests.
CoAxia, of Maple Grove, Minn., announced the HDE
approval of its new NeuroFlo dual balloon, aortic catheter for the treatment
of cerebral ischemia in acute vasospasm.
Impulse Dynamics has announced that it has begun a Phase II clinical study to
investigate the safety and effectiveness of a new implantable pulse generator
called the OPTIMIZER III and that the first patient in the Phase II study was
successfully implanted at St. Joseph's Hospital in Atlanta.